Key points:
- The Myhealthchecked share price surged 11.1% on the Amazon UK launch.
- The company just launched the sale of its at-home tests on Amazon UK.
- Will consumers embrace the tests? Read on to find out.
The Myhealthchecked PLC (LON: MHC) share price surged 11.1% after launching the sale of its at-home test kits on Amazon.com’s UK website. Investors cheered the move to bring the company’s test kits to millions of Amazon’s UK customers.
The tests on Amazon are part of the company’s wellness range, including at-home tests for intolerances & sensitivity, weight management, heart profile, vitamins & minerals. The at-home tests allow people to identify genetic traits associated with intolerances, such as lactose and gluten intolerance.
Also read: The Best Healthcare Stocks To Buy Right Now.
Tests for weight management allow users to identify their genetic predisposition to gaining weight & becoming overweight and their responsiveness to weight loss programs from a metabolic and molecular level.
The company noted that the wide availability of its at-home tests allows individuals to make informed choices about their health by understanding their bodies’ metabolism from a molecular perspective.
Investors cheered the announcement as Myhealthchecked said that the availability of its test kits on Amazon UK’s website would give people the power to be proactive about their health and take measures to align their lifestyles with their health goals.
The move comes when consumers are pretty conscious of their health following the impact of the COVID-19 pandemic. However, only time will tell whether the uptake of the tests among consumers will be as high as anticipated.
Penny McCormick, MyHealthChecked Plc’s CEO, said: “We are excited to be launching our wellness tests with Amazon and believe this will greatly increase the accessibility of our product range. Following the success of our partnership with the UK’s top high street pharmacy retailers for our COVID testing service, we have seen the real value that additional retail partners can bring to the business by broadening our customer base and significantly increasing our market share.”
So, should you buy Myhealthchecked’s shares? MHC shares are down 14.89% in 2022, which is much better than the overall market’s performance. However, the shares are trading in the middle of a wide range; hence, I wouldn’t buy them at current prices.
*This is not investment advice. Always do your due diligence before making investment decisions.
The Myhealthchecked share price chart.
The Myhealthchecked share price surged 11.11% to trade at 2.00p, rising from Monday’s closing price of 1.80p.
